ATE190839T1 - Verwendung von prodelphidinen zur behandlung von arthrose - Google Patents

Verwendung von prodelphidinen zur behandlung von arthrose

Info

Publication number
ATE190839T1
ATE190839T1 AT94903924T AT94903924T ATE190839T1 AT E190839 T1 ATE190839 T1 AT E190839T1 AT 94903924 T AT94903924 T AT 94903924T AT 94903924 T AT94903924 T AT 94903924T AT E190839 T1 ATE190839 T1 AT E190839T1
Authority
AT
Austria
Prior art keywords
pct
prodelphidine
arthrosis
sec
date
Prior art date
Application number
AT94903924T
Other languages
English (en)
Inventor
Paul Franchimont
Corine Bassleer
Luc Angenot
Monique Tits
Original Assignee
Dolisos Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dolisos Lab filed Critical Dolisos Lab
Application granted granted Critical
Publication of ATE190839T1 publication Critical patent/ATE190839T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT94903924T 1992-12-28 1993-12-28 Verwendung von prodelphidinen zur behandlung von arthrose ATE190839T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9215801A FR2699819B1 (fr) 1992-12-28 1992-12-28 Utilisation de prodelphinidines pour l'obtention de médicaments destinés au traitement de l'arthrose.
PCT/FR1993/001312 WO1994014432A1 (fr) 1992-12-28 1993-12-28 Utilisation de prodelphinidines pour le traitement de l'arthrose

Publications (1)

Publication Number Publication Date
ATE190839T1 true ATE190839T1 (de) 2000-04-15

Family

ID=9437179

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94903924T ATE190839T1 (de) 1992-12-28 1993-12-28 Verwendung von prodelphidinen zur behandlung von arthrose

Country Status (10)

Country Link
US (1) US5670538A (de)
EP (1) EP0675713B1 (de)
JP (1) JPH08504213A (de)
AT (1) ATE190839T1 (de)
AU (1) AU702124B2 (de)
CA (1) CA2152506C (de)
DE (1) DE69328193D1 (de)
FR (1) FR2699819B1 (de)
NZ (1) NZ259393A (de)
WO (1) WO1994014432A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5650432A (en) * 1995-03-24 1997-07-22 Jlb, Inc. Method of treating or preventing non-viral microbial infection
JPH0725761A (ja) * 1993-07-09 1995-01-27 Kureha Chem Ind Co Ltd 軟骨保護剤
JPH1059846A (ja) * 1996-06-10 1998-03-03 Kikkoman Corp 白内障の予防または治療薬剤
DE69840211D1 (de) * 1997-09-09 2008-12-24 Univ Rutgers Proanthocyanidinhaltiges pflanzenextrakt für die hemmung von p-type fimbriae-bakterieller adhäsion an oberflächen
JP4507027B2 (ja) * 1998-12-04 2010-07-21 明治乳業株式会社 Ｍｍｐ阻害剤
US6589235B2 (en) * 2000-01-21 2003-07-08 The Regents Of The University Of California Method and apparatus for cartilage reshaping by radiofrequency heating
JP2006016367A (ja) * 2004-07-05 2006-01-19 Suntory Ltd リパーゼ阻害剤
US8697139B2 (en) 2004-09-21 2014-04-15 Frank M. Phillips Method of intervertebral disc treatment using articular chondrocyte cells
US20070014883A1 (en) * 2005-07-13 2007-01-18 Peter Rohdewald Method for treating osteoarthritis
JP5253862B2 (ja) * 2008-03-31 2013-07-31 株式会社ナリス化粧品 メラニン産性抑制剤・コラーゲン産生促進剤
CN106456797A (zh) 2014-05-15 2017-02-22 新加坡科技研究局 聚合物‑类黄酮缀合物及其用途
JP2015147798A (ja) * 2015-04-20 2015-08-20 ビーエーエスエフ ビューティ ケア ソリューションズ フランス エスエーエス 弾性繊維の形成を刺激するための、ｌｏｘｌ（リシルオキシダーゼ類似）アイソフォームの合成及び活性の刺激
JP7089274B2 (ja) * 2018-03-02 2022-06-22 国立大学法人信州大学 エピガロカテキンを含むオリゴマーおよびその製造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4268517A (en) * 1979-08-30 1981-05-19 Continental Pharma Pharmaceutical composition and therapeutical method for treating degenerative affections of the articular cartilage
US4698360B1 (en) * 1985-04-09 1997-11-04 D Investigations Pharmacologiq Plant extract with a proanthocyanidins content as therapeutic agent having radical scavenger effect and use thereof
FR2672800B1 (fr) * 1991-02-15 1995-03-10 Dolisos Lab Nouvelle utilisation en therapeutique de pycnogenols pour la preparation de medicaments a activite anti-inflammatoire.

Also Published As

Publication number Publication date
US5670538A (en) 1997-09-23
AU702124B2 (en) 1999-02-11
EP0675713A1 (de) 1995-10-11
DE69328193D1 (de) 2000-04-27
WO1994014432A1 (fr) 1994-07-07
CA2152506A1 (fr) 1994-07-07
FR2699819A1 (fr) 1994-07-01
JPH08504213A (ja) 1996-05-07
NZ259393A (en) 1997-05-26
FR2699819B1 (fr) 1995-02-24
AU5818394A (en) 1994-07-19
EP0675713B1 (de) 2000-03-22
CA2152506C (fr) 2006-01-31

Similar Documents

Publication Publication Date Title
ATE164067T1 (de) Verwendung von riluzole zur behandlung von traumatischen neurologischen-schädigungen
DE69507029D1 (de) Pharmazeutische zusammensetzungen enthaltend einen opiat antagonist und calcium salze, ihre verwendung zur behandlung von endorphin-vermittelten krankheiten
DE59409312D1 (de) Imidazopyridine und ihre anwendung zur behandlung von magen-darm krankheiten
DE69428791D1 (de) Verwendung vonModafinil zur Behandlung von Atemstillstand im Schlaf und zentral erregten Atembeschwerden
ATE233558T1 (de) Verwendung von strontiumsälze zur behandlung von arthrose
DE69805202D1 (de) Verwendung von benzhydrylsulfinylderivaten zur behandlung der schläfigkeit medikamentösen ursprungs
ATE225176T1 (de) Verwendung von serotonin-antagonisten (5ht3) zur behandlung von fibromyalgie
DE69625691D1 (de) Verabreichung von peptidylheterocyclen zur behandlung von thrombin in zusammenhang stehenden krankheiten
ATE321548T1 (de) Verwendung von statin zur behandlung von hauterkrankungen
DE69526937D1 (de) Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen
ATE262336T1 (de) Verwendung von 9-desoxy-2',9-alpha-methano-3-oxa- 4,5,6-trinor-3,7-(1',3'-interphenylen)-13,14- dihydroprostaglandin-f1 zur behandlung von peripheren vaskulären erkrankungen
DE69921156D1 (de) Verwendung von 5ht-6 antagonisten zur behandlung adhd
ATE190839T1 (de) Verwendung von prodelphidinen zur behandlung von arthrose
ATE207356T1 (de) Verwendung von tiagabin zur behandlung von schlafstörungen
ATE210447T1 (de) Verwendung von cck-b rezeptor antagonisten zur behandlung von schlafstörungen
ATE241981T1 (de) Verwendung von 4-aminopyridin zur behandlung von schmerz und spastik folgende einer verletzung des rückenmarks
ATE214272T1 (de) Topische verwendung von kappa- opioidrezeptoragonisten zur behandlung von augenschmerz
DE59209728D1 (de) VERWENDUNG VON ANTAGONISTEN ODER PARTIELLEN AGONISTEN AM 5-HT 1a-REZEPTOR ZUR BEHANDLUNG UND PRÄVENTION VON KOGNITIVEN STÖRUNGEN
DE59107536D1 (de) Arzneimittel zur behandlung von hyperlipidämie und/oder atherosklerose
ATE143947T1 (de) N-acylpyrrolidine und arzneimittel zur behandlung oder prophylaxe von mit ckk und gastrin in zusammenhang stehenden krankheiten
ATE189385T1 (de) Verwendung von benzonaphtalene-derivaten zur herstellung eines arzneimittels zur behandlung von krankheiten des nervensystems
DE69427116D1 (de) Verwendung von 4'-iodo - 4 - deoxydoxorubicin zur behandlung von amyloidosis
ATE230608T1 (de) Verwendung von bradykinin-antagonisten zur herstellung von arzneimitteln zur behandlung und prävention der alzheimer'schen krankheit
ATE195422T1 (de) Verwendung von piperazinderivaten zur behandlung von kognitiven erkrankungen
DE59409813D1 (de) Imidazolochinoxalinone zur behandlung zentralnervöser erkrankungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties